Find policies, billing codes, payers, states, and providers
CPT 78121: Red Cell Volume Measurement, Multiple Sample Method
CPT code 78121 denotes a nuclear medicine procedure to measure red cell volume using a multiple-sample radioactive tracer technique. This test quantifies circulating red blood cell volume for diagnostic and treatment planning purposes in hematology and related specialties. Nationally, accurate reporting of this code supports clinical decision-making for anemia evaluation, blood loss assessment, and monitoring of therapies that affect blood volume.
Key payers in the analysis include Aetna, Blue Cross Blue Shield, Cigna Health, UnitedHealthcare, and Medicare. Readers will find a concise reference to billing context, typical sites of service, and the clinical role of the procedure. The publication summarizes common payer considerations and available benchmarking where present, outlines coding specifics relevant to claims processing, and situates the service within clinical workflows in hospital outpatient and specialized laboratory settings.
This summary addresses what the code represents, why it matters in patient care and reimbursement workflows, and what practitioners and billing staff should know about documentation and reporting expectations. Data not available in the input is noted where applicable in the full publication.
Customize your policy alerts
Sign up for cpt 78121 policy alerts
Get alerted when payer policies referencing 78121 are released or updated.
Monitor payer policy activity
Billing Code Overview
CPT code 78121 describes a laboratory procedure to determine red cell volume by introducing a known quantity of red blood cells labeled with a radioactive tracer and measuring tracer concentration after adequate mixing. This entry represents the multiple sample method for measuring red blood cell volume and is used to quantify a blood component for clinical assessment.
Service Type: Nuclear medicine / hematology diagnostic test
Typical Site of Service: Hospital outpatient departments, hospital-based laboratories, and specialized diagnostic imaging or nuclear medicine facilities